Author:
Nguyen Anh P.,Binswanger Ingrid A.,Narwaney Komal J.,Ford Morgan A.,McClure David L.,Rinehart Deborah J.,Lyons Jason A.,Glanz Jason M.
Funder
National Institutes of Health
National Institute on Drug Abuse
Reference33 articles.
1. Racial differences in COVID-19 severity associated with history of substance use disorders and overdose: findings from multi-site electronic health records in New York City;Allen;Prev. Med.,2023
2. The impact of substance use disorder on COVID-19 outcomes;Baillargeon;Psychiatr. Serv.,2021
3. Population risk factors for severe disease and mortality in COVID-19: a global systematic review and meta-analysis;Booth;PLoS One,2021
4. Centers for Disease Control and Prevention. COVID-19 and Your Health. COVID-19 Treatments and Medications. Published February 11, 2020. Accessed April 29, 2024. https://www.cdc.gov/coronavirus/2019-ncov/your-health/treatments-for-severe-illness.html.
5. Centers for Disease Control and Prevention. COVID Data Tracker. Published April 29, 2024. Accessed April 30, 2024. https://covid.cdc.gov/covid-data-tracker.